Skip to main content

previous disabled Page of 4
and
  1. Article

    Open Access

    Development and validation of a preoperative CT‑based radiomics nomogram to differentiate tuberculosis granulomas from lung adenocarcinomas: an external validation study

    An accurate and non-invasive approach is urgently needed to distinguish tuberculosis granulomas from lung adenocarcinomas. This study aimed to develop and validate a nomogram based on contrast enhanced-compute...

    Li** Yang, Zhiyun Jiang, **long Tong, Nan Li, Qing Dong, Kezheng Wang in BMC Cancer (2024)

  2. Article

    Open Access

    A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study

    Accurate microsatellite instability (MSI) testing is essential for identifying gastric cancer (GC) patients eligible for immunotherapy. We aimed to develop and validate a CT-based radiomics signature to predic...

    Peng-chao Zhan, Shuo Yang, **ng Liu, Yu-yuan Zhang, Rui Wang, Jia-xing Wang in BMC Cancer (2024)

  3. Article

    Open Access

    Red blood cell distribution width is associated with sarcopenia risk in early-stage non-small cell lung cancer

    Sarcopenia has received increasing attention in non-small cell lung cancer (NSCLC). Red blood cell distribution width (RDW) is a significant component of the complete blood count and indicates the heterogeneit...

    Qing-chun Jia, Ling Qin, Ye Niu, Le Liu, **-** Liu, Shi-di Miao in BMC Cancer (2024)

  4. Article

    Open Access

    NUSAP1 promotes pancreatic ductal adenocarcinoma progression by drives the epithelial-mesenchymal transition and reduces AMPK phosphorylation

    Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, and its molecular mechanisms are unclear. Nucleolar and spindle-associated protein 1 (NUSAP1), an indispensable mitotic regulator, has been reporte...

    Yuan Liu, Rong Tang, Qing-Cai Meng, Si Shi, ** Xu, **an-Jun Yu, Bo Zhang in BMC Cancer (2024)

  5. Article

    Open Access

    Phase I dose escalation study and pilot efficacy analysis of LXI-15029, a novel mTOR dual inhibitor, in Chinese subjects with advanced malignant solid tumors

    The mammalian target of rapamycin (mTOR) kinase, a central component of the PI3K/AKT/mTOR pathway, plays a critical role in tumor biology as an attractive therapeutic target. We conducted this first-in-human s...

    Jiani Wang, Lin Gui, Yuxin Mu, Jiayu Wang, Yihebali Chi, Zhenteng Liu in BMC Cancer (2023)

  6. Article

    Open Access

    Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients

    Routine clinical staging for hepatocellular carcinoma (HCC) incorporates liver function, general health, and tumor morphology. Further refinement of prognostic assessments and treatment decisions may benefit f...

    Kong-Ying Lin, Qing-**g Chen, Shi-Chuan Tang, Zhi-Wen Lin, Jian-** Zhang in BMC Cancer (2023)

  7. Article

    Open Access

    The analysis of HPV integration sites based on nanopore sequencing and the profiling changes along the course of photodynamic therapy

    To detect the HPV genotype and integration sites in patients with high-risk HPV infection at different stages of photodynamic therapy using nanopore technology and to evaluate the treatment effect.

    **ulan Li, **aoke Wei, **n Liu, Nan Wang, Fuqiang Xu, **ngyu Liu, Yanmei Li in BMC Cancer (2023)

  8. Article

    Open Access

    Evaluation of dynamic recurrence risk for locally advanced gastric cancer in the clinical setting of adjuvant chemotherapy: a real-world study with IPTW-based conditional recurrence analysis

    The long-term dynamic recurrence hazard of locally advanced gastric cancer (LAGC) in the clinical setting of adjuvant chemotherapy (ACT) remains unclear.

    Dong Wu, Jun Lu, Zhen Xue, Qing Zhong, Bin-bin Xu, Hua-Long Zheng in BMC Cancer (2023)

  9. Article

    Open Access

    Network Evolution Model-based prediction of tumor mutation burden from radiomic-clinical features in endometrial cancers

    Endometrial Cancer (EC) is one of the most prevalent malignancies that affect the female population globally. In the context of immunotherapy, Tumor Mutation Burden (TMB) in the DNA polymerase epsilon (POLE) s...

    Qing Tan, Qian Wang, Suoqin **, Fuling Zhou, **ufen Zou in BMC Cancer (2023)

  10. Article

    Open Access

    The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma

    Pancreatic ductal adenocarcinoma (PDAC) is a malignancy characterized by challenging early diagnosis and poor prognosis. It is believed that coagulation has an impact on the tumor microenvironment of PDAC. The...

    Di Wang, Song-** Cui, Qing Chen, Zhang-yong Ren, Shao-cheng Lyu, **n Zhao in BMC Cancer (2023)

  11. Article

    Open Access

    PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation

    The ubiquity-proteasome system is an indispensable mechanism for regulating intracellular protein degradation, thereby affecting human antigen processing, signal transduction, and cell cycle regulation. We use...

    **ao Li, **nru Li, Yuexin Hu, Ouxuan Liu, Yuxuan Wang, Siting Li, Qing Yang in BMC Cancer (2023)

  12. Article

    Open Access

    Clinical activity of pembrolizumab with or without chemotherapy in advanced pulmonary large-cell and large-cell neuroendocrine carcinomas: a multicenter retrospective cohort study

    Immune checkpoint inhibitors (ICI)-based combination strategies have improved the survival outcomes in advanced non-small cell lung cancers; however, data regarding their efficacy remains limited for uncommon ...

    Lianxi Song, Fei Zhou, Tian Xu, Liang Zeng, Qing **a, Zhan Wang, Li Deng in BMC Cancer (2023)

  13. Article

    Open Access

    Identification of ZBTB4 as an immunological biomarker that can inhibit the proliferation and invasion of pancreatic cancer

    Zinc finger and BTB domain-containing protein 4 (ZBTB4) belongs to the zinc finger protein family, which has a role in regulating epigenetic inheritance and is associated with cell differentiation and prolifer...

    Zhe Yang, Feiran Chen, Feng Wang, **ubing Chen, Biaolin Zheng, **aomin Liao in BMC Cancer (2023)

  14. Article

    Open Access

    Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study

    Pucotenlimab is a novel recombinant humanized anti-PD-1 (Programmed death-1) monoclonal antibody, which belongs to the human IgG4/kappa subtype, and can selectively block the binding of PD-1 with its ligands P...

    Chuanliang Cui, Yu Chen, Zhiguo Luo, Zhengyun Zou, Yu Jiang, Hongming Pan in BMC Cancer (2023)

  15. Article

    Open Access

    Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma

    To explore the potential pathogenesis and clinical features of second primary glioblastoma (spGBM) following first primary renal cell carcinoma (fpRCC).

    Guang-Tao Zhang, Qi Liu, Fu-**ng Zuo, Hou-Jie Liu, Song-Quan Wang, Qing Yuan in BMC Cancer (2023)

  16. Article

    Open Access

    MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells

    Metabolic reprogramming is a hallmark of cancer, alteration of nucleotide metabolism of hepatocellular carcinoma (HCC) is not well-understood. MYBL2 regulates cell cycle progression and hepatocarcinogenesis, i...

    Jun-Zhang Zhao, Wei Wang, Tao Liu, Lei Zhang, De-Zheng Lin, Jia-Yin Yao in BMC Cancer (2022)

  17. Article

    Open Access

    STEAP3 can predict the prognosis and shape the tumor microenvironment of clear cell renal cell carcinoma

    Clear cell renal cell carcinoma (ccRCC) is a common malignant tumor of the urinary system characterized by poor prognosis and difficult treatment. It has been reported that iron metabolism dysregulation is a c...

    Jiyue Wu, Qing Bi, **ang Zheng, Huawei Cao, Changzhen Hao, Zejia Sun in BMC Cancer (2022)

  18. Article

    Open Access

    Quantifying substantial carcinogenesis of genetic and environmental factors from measurement error in the number of stem cell divisions

    The relative contributions of genetic and environmental factors versus unavoidable stochastic risk factors to the variation in cancer risk among tissues have become a widely-discussed topic. Some claim that th...

    **nhui Liu, Jifeng Yang, Hongkai Li, Qing Wang, Yuanyuan Yu, **aoru Sun in BMC Cancer (2022)

  19. Article

    Open Access

    Failure pattern and suggestions for target volume delineation of carcinoma showing thymus-like differentiation treated with intensity-modulated radiotherapy

    To review our long-term clinical experience, analyze the failure patterns, and give suggestions for target volume delineation of carcinoma showing thymus-like differentiation (CASTLE) treated with intensity-mo...

    Fang-Fang Kong, Guang-Sen Pan, Rui-** Zhai, Cheng-Run Du, **a-Yun He in BMC Cancer (2022)

  20. Article

    Open Access

    Sintilimab plus docetaxel as second-line therapy of advanced non-small cell lung cancer without targetable mutations: a phase II efficacy and biomarker study

    Single-agent immunotherapy is currently the recommended second-line therapy for patients with advanced non–small cell lung cancer (NSCLC) without targetable mutations; however, the objective response rate (ORR...

    Yongchang Zhang, Lianxi Song, Liang Zeng, Yi **ong, Li Liu, Chunhua Zhou in BMC Cancer (2022)

previous disabled Page of 4